Presence of somatomedin receptors on primary human breast and colon carcinomas

Cancer Lett. 1987 Dec;38(1-2):223-30. doi: 10.1016/0304-3835(87)90218-7.

Abstract

Competitive binding techniques were used to study the interaction of insulin-like growth factor I (IGF-I) with a plasma membrane-enriched subcellular fraction purified from primary breast and colon carcinoma specimens obtained at surgery. The presence of specific binding sites for IGF-I was detected in all tumour specimens studied. Scatchard analysis and competition studies with insulin and insulin-like growth factor-II (IGF-II) revealed the presence of specific IGF-I receptors, showing a Kd-value of approximately 2 nM. These results are consistent with the hypothesis that somatomedins play a role in determining the proliferative behaviour of human breast and colon tumors, and suggest that recent laboratory studies showing dependence of neoplastic cells on somatomedins for optimum proliferation may have clinical relevance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Breast Neoplasms / analysis*
  • Cell Division / drug effects
  • Colonic Neoplasms / analysis*
  • Female
  • Humans
  • Insulin-Like Growth Factor I / metabolism
  • Receptor, Insulin / analysis*
  • Receptors, Somatomedin
  • Somatomedins / pharmacology

Substances

  • Receptors, Somatomedin
  • Somatomedins
  • Insulin-Like Growth Factor I
  • Receptor, Insulin